Prescription Opioids: Risk Management and Strategies for Safe Use _ _________________________________ 3. Which of the following is NOT a characteristic of substance addiction according to the American Society of Addiction Medicine?
9. Which of the following is FALSE regarding extended- release opioids before the 1990s? A) Most of the agents required IV or IM administration. B) Their outpatient use was mainly limited to cancer patients. C) Their use was mostly limited to operating room and inpatient settings. D) They were widely available to outpatients, but under very strict controls.
A) Inability to consistently abstain B) Impairment in behavioral control C) A functional emotional response D) Diminished recognition of significant problems
with one’s behaviors and interpersonal relationships
4. Which of the following is TRUE regarding aberrant drug use/seeking behaviors? A) They occur at very low rates. B) They almost always reflect an emerging opioid use problem. C) They can always be predicted with careful pre-opioid therapy assessment. D) Even when strongly suggestive of opioid use
10. Which of the following has NOT contributed to the increasing prevalence of chronic pain? A) The aging population
B) Advances in lifesaving trauma interventions C) Rising rates of obesity and obesity-related pain conditions D) Poor public awareness of pain as a condition warranting medical attention
disorder, they can be driven by relief seeking for physical (pain) or emotional distress.
5. Which of the following behaviors is the most suggestive of an emerging opioid use disorder? A) Asking for specific medications B) Injecting medications meant for oral use
11. Americans consume what percentage of worldwide hydrocodone consumption?
A) 35% B) 55% C) 80% D) 99%
C) Reluctance to decrease opioid dosing once stable D) Stockpiling medications during times when pain is less severe
12. As of April 2020, how many states have passed laws that address opioid analgesic prescribing? A) 5 B) 20 C) 40 D) All 50 and the District of Columbia 13. As of 2023, more than 90% of opioid prescriptions have been for A) ER/LA opioids. B) short-acting opioids. C) immediate-release opioids. D) Both B and C 14. Which of the following factors influences the decision to prescribe an opioid analgesic? A) Patient preference
6. Which of the following has NOT contributed to the historic, widespread pattern of pain undertreatment in the United States?
A) Absence of effective analgesic medications B) Fear of patient addiction if opioids were prescribed C) Concerns over regulatory scrutiny and sanction if opioids were prescribed D) Dismissal of pain as an endurable symptom of a primary illness or condition
7. Which of the following did NOT contribute to broad expansion and indications for opioid prescribing for pain in the 1990s to early 2000s?
A) DEA cooperation B) FSMB reassurance C) Congressional legislature D) Pharmaceutical industry influence
B) Clinician knowledge and judgment C) Aggressive pharmaceutical marketing D) All of the above
8. Which of the following opioids showed increased retail purchases from 2019 to 2021? A) Fentanyl
B) Methadone C) Meperidine D) Hydromorphone
56
MDMS1526
Powered by FlippingBook